Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ES9U
|
|||
| Drug Name |
COR-003
|
|||
| Synonyms |
Panfungol; Orifungal M; Nizoral; Ketozole; Normocort; 65277-42-1; Ketoisdin; Nizoral a-D; Sebazole; Levoketoconazole; UNII-2DJ8R0NT7K; Ketoconazolum [INN-Latin]; Ketoconazol [INN-Spanish]; Ketoconazole, (2S,4R)-; (2S,4R)-ketoconazole; 142128-57-2; 2DJ8R0NT7K; Ketocanazole; Ketoconazolum; Brizoral; CHEMBL295698; CHEBI:47518; HSDB 7447; Terzolin; Teryzolin; EINECS 265-667-4; Onofin K; NSC 317629; BRN 4303081; 1-acetyl-4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imi
Click to Show/Hide
|
|||
| Indication | Cushing disease [ICD-11: 5A70; ICD-10: E24; ICD-9: 255] | Phase 3 | [1] | |
| Company |
Stonebridge Biopharma Trevose, PA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H28Cl2N4O4
|
|||
| Canonical SMILES |
CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
|
|||
| InChI |
1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1
|
|||
| InChIKey |
XMAYWYJOQHXEEK-ZEQKJWHPSA-N
|
|||
| CAS Number |
CAS 142128-57-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:47518
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.